Agents Without Owners: What RSA 2026 Revealed About the Agentic AI Governance Gap Explore agentic AI governance challenges as deployment outpaces existing security frameworks across organizations. Brian Rankin - March 27, 2026 Blogs Biotech, Medical Device, Pharma Information Technology, Quality Assurance, Regulatory
From Phase 3 Win to NDA: The GxP Readiness Gaps That Sink Clinical-Stage Oncology Biotechs Most clinical-stage biotechs celebrate Phase 3 wins without realizing their GxP infrastructure isn't ready for NDA-level FDA scrutiny. Here are the 5 gaps that derail NDA submissions — and how to close them. Kevin Brown - March 23, 2026 Blogs Biotech, CMO, CRO Clinical, Information Technology, Manufacturing, Quality Assurance, Regulatory
From Legacy Systems to Intelligent Content Planning A biopharma’s journey from legacy RIM systems to intelligent content planning—powered by USDM’s strategic, AI-ready approach. Lisa Om - January 23, 2026 Case Studies Pharma Regulatory
What’s Actually Compliant in AI for Life Sciences? A 2026 Reality Check Explore what AI compliance means in 2026 for life sciences. Learn key FDA, EU AI Act insights, validation tips, and how to scale AI responsibly. John Petrakis - December 19, 2025 Blogs Biotech, Medical Device, Pharma Information Technology, Quality Assurance, Regulatory
USDM Life Sciences Summit 2026 WATCH ON-DEMAND to explore AI, digital trust, automation, and compliant transformation. Innovation at the speed of change. Webinars Biotech, CMO, CRO, Medical Device, Pharma Clinical, Information Technology, Manufacturing, Quality Assurance, Regulatory, Research & Development, Safety
EUDAMED Has Landed – What It Means for You, Now On-Demand: Discover what the EUDAMED launch means for MDR/IVDR compliance—and how to stay audit-ready with USDM’s expert guidance. Watch now. On Demand, Webinars Medical Device Regulatory
